| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF571 ZNF397 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF66 ZNF506 PRDM15 GLIS1 ZNF345 | 1.05e-10 | 1244 | 96 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF571 ZNF397 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF66 ZNF506 PRDM15 GLIS1 ZNF345 | 1.68e-10 | 1271 | 96 | 26 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF571 ZNF397 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF66 ZNF506 PRDM15 ZNF614 GLIS1 ZNF345 | 3.08e-10 | 1412 | 96 | 27 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF571 ZNF397 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF66 ZNF506 PRDM15 ZNF614 GLIS1 ZNF345 | 6.35e-10 | 1459 | 96 | 27 | GO:0000977 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.36e-04 | 4 | 96 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.56e-04 | 320 | 96 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.77e-04 | 326 | 96 | 8 | GO:0001217 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 3.39e-04 | 6 | 96 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ubiquitin-modified histone reader activity | 4.73e-04 | 7 | 96 | 2 | GO:0061649 | |
| Domain | zf-C2H2 | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 2.45e-21 | 693 | 95 | 31 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 6.37e-20 | 775 | 95 | 31 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 6.86e-20 | 777 | 95 | 31 | PS00028 |
| Domain | Znf_C2H2 | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 1.91e-19 | 805 | 95 | 31 | IPR007087 |
| Domain | ZnF_C2H2 | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 2.12e-19 | 808 | 95 | 31 | SM00355 |
| Domain | - | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 2.25e-19 | 679 | 95 | 29 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 4.07e-19 | 694 | 95 | 29 | IPR013087 |
| Domain | Znf_C2H2-like | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 1.54e-18 | 796 | 95 | 30 | IPR015880 |
| Domain | KRAB | ZNF562 ZNF274 ZNF157 ZNF175 ZNF571 ZNF230 ZNF251 ZNF419 ZNF776 ZNF100 ZNF382 ZNF728 ZNF253 ZNF506 ZNF614 | 3.56e-10 | 358 | 95 | 15 | PS50805 |
| Domain | KRAB | ZNF562 ZNF274 ZNF157 ZNF175 ZNF571 ZNF230 ZNF251 ZNF419 ZNF776 ZNF100 ZNF382 ZNF728 ZNF253 ZNF506 ZNF614 | 3.56e-10 | 358 | 95 | 15 | PF01352 |
| Domain | KRAB | ZNF562 ZNF274 ZNF157 ZNF175 ZNF571 ZNF230 ZNF251 ZNF419 ZNF776 ZNF100 ZNF382 ZNF728 ZNF253 ZNF506 ZNF614 | 5.41e-10 | 369 | 95 | 15 | SM00349 |
| Domain | KRAB | ZNF562 ZNF274 ZNF157 ZNF175 ZNF571 ZNF230 ZNF251 ZNF419 ZNF776 ZNF100 ZNF382 ZNF728 ZNF253 ZNF506 ZNF614 | 5.61e-10 | 370 | 95 | 15 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF562 ZNF157 ZNF521 ZNF571 ZNF251 ZNF419 ZNF526 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF345 | 6.49e-10 | 314 | 95 | 14 | PF13912 |
| Domain | TF_Ovo-like | 2.56e-05 | 2 | 95 | 2 | IPR027755 | |
| Domain | Ryanrecept_TM4-6 | 7.65e-05 | 3 | 95 | 2 | IPR009460 | |
| Domain | RyR | 7.65e-05 | 3 | 95 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 7.65e-05 | 3 | 95 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 7.65e-05 | 3 | 95 | 2 | PF06459 | |
| Domain | Ryan_recept | 7.65e-05 | 3 | 95 | 2 | IPR013333 | |
| Domain | RIH_assoc | 3.79e-04 | 6 | 95 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.79e-04 | 6 | 95 | 2 | IPR013662 | |
| Domain | RIH_dom | 3.79e-04 | 6 | 95 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.79e-04 | 6 | 95 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.79e-04 | 6 | 95 | 2 | IPR015925 | |
| Domain | - | 3.79e-04 | 6 | 95 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.79e-04 | 6 | 95 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 3.79e-04 | 6 | 95 | 2 | PF08709 | |
| Domain | MIR | 1.12e-03 | 10 | 95 | 2 | PS50919 | |
| Domain | MIR | 1.12e-03 | 10 | 95 | 2 | PF02815 | |
| Domain | MIR | 1.12e-03 | 10 | 95 | 2 | SM00472 | |
| Domain | MIR_motif | 1.12e-03 | 10 | 95 | 2 | IPR016093 | |
| Domain | - | 1.63e-03 | 12 | 95 | 2 | 3.40.50.1010 | |
| Domain | PIN_domain-like | 2.24e-03 | 14 | 95 | 2 | IPR029060 | |
| Domain | zf-H2C2_2 | 2.24e-03 | 14 | 95 | 2 | PF13465 | |
| Domain | TPR_8 | 2.48e-03 | 53 | 95 | 3 | PF13181 | |
| Domain | C2H2_Znf_fam | 6.57e-03 | 24 | 95 | 2 | IPR027775 | |
| Domain | ZnF_U1 | 9.51e-03 | 29 | 95 | 2 | SM00451 | |
| Domain | Znf_U1 | 9.51e-03 | 29 | 95 | 2 | IPR003604 | |
| Domain | SPRY | 9.93e-03 | 87 | 95 | 3 | SM00449 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF571 ZNF230 FAS ZNF419 CCNT2 ZNF776 ZNF100 BRD2 CTR9 ZNF382 ZNF253 ZNF506 ZNF614 | 2.32e-05 | 1387 | 63 | 18 | M734 |
| Pubmed | 4.86e-08 | 181 | 98 | 8 | 37372979 | ||
| Pubmed | BNC2 SP3 ZNF274 ZNF175 ZNF397 OVOL2 ZNF419 JARID2 OVOL1 BRD2 ZNF506 ZNF653 GLIS1 | 4.56e-07 | 808 | 98 | 13 | 20412781 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RNF169 SETX OGT ERCC6 FSIP2 ZNF776 BRD2 PIN4 FEN1 PRDM15 SENP7 | 1.21e-06 | 608 | 98 | 11 | 36089195 |
| Pubmed | RNF169 RTEL1 EXPH5 RNF213 ZNF407 FARP2 ZNF526 CEP152 FGD6 HERPUD1 | 1.38e-06 | 493 | 98 | 10 | 15368895 | |
| Pubmed | Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma. | 7.86e-06 | 2 | 98 | 2 | 26873447 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.86e-06 | 2 | 98 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.86e-06 | 2 | 98 | 2 | 26009179 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17049212 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32899693 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 30542613 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 7.86e-06 | 2 | 98 | 2 | 11673493 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11673462 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29395064 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7878058 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 7.86e-06 | 2 | 98 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 7.86e-06 | 2 | 98 | 2 | 15033925 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 7.86e-06 | 2 | 98 | 2 | 18618700 | |
| Pubmed | 1.55e-05 | 650 | 98 | 10 | 38777146 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 22737237 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 18403125 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 9808631 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 18434746 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 29671873 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 2.35e-05 | 3 | 98 | 2 | 9204703 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 7876312 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 21881589 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 24123915 | ||
| Pubmed | Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses. | 2.35e-05 | 3 | 98 | 2 | 32240120 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 28339425 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 2.35e-05 | 3 | 98 | 2 | 12213830 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 23278119 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 9242641 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 2.35e-05 | 3 | 98 | 2 | 23454728 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 2.35e-05 | 3 | 98 | 2 | 10788707 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 2.35e-05 | 3 | 98 | 2 | 7621815 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 18643873 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 11159936 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 2.35e-05 | 3 | 98 | 2 | 9986730 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 2.35e-05 | 3 | 98 | 2 | 10473538 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 2.35e-05 | 3 | 98 | 2 | 4600883 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 7635066 | ||
| Pubmed | ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation. | 2.40e-05 | 59 | 98 | 4 | 34108663 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 18206662 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 22504960 | ||
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 4.70e-05 | 4 | 98 | 2 | 23992453 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.70e-05 | 4 | 98 | 2 | 23413940 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 9384575 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 9607712 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 27226555 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 19120137 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 4.70e-05 | 4 | 98 | 2 | 11237759 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 23482488 | ||
| Pubmed | SP3 RNF169 SETX OGT ERCC6 FARP2 JARID2 CELSR1 SHANK2 BRD2 CTR9 STRN4 XRN1 ANKRD11 | 7.80e-05 | 1497 | 98 | 14 | 31527615 | |
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 7.82e-05 | 5 | 98 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 7.82e-05 | 5 | 98 | 2 | 9124414 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 7.82e-05 | 5 | 98 | 2 | 19011160 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 19549818 | ||
| Pubmed | USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination. | 1.17e-04 | 6 | 98 | 2 | 36567903 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.17e-04 | 6 | 98 | 2 | 26025922 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 1.17e-04 | 6 | 98 | 2 | 14592808 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.17e-04 | 6 | 98 | 2 | 25966694 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.17e-04 | 6 | 98 | 2 | 16844763 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.17e-04 | 168 | 98 | 5 | 30631154 | |
| Pubmed | 1.40e-04 | 399 | 98 | 7 | 35987950 | ||
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 11860456 | ||
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.18e-04 | 8 | 98 | 2 | 19033399 | |
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 11784029 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RYR1 CELSR1 OVOL1 SHANK2 BRD2 STRN4 ANKRD11 BAMBI ZNF614 AP3D1 ANKRD16 | 2.85e-04 | 1105 | 98 | 11 | 35748872 |
| Pubmed | A genome-wide association study identifies three new risk loci for Kawasaki disease. | 3.48e-04 | 10 | 98 | 2 | 22446962 | |
| Pubmed | OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor. | 3.48e-04 | 10 | 98 | 2 | 35484112 | |
| Pubmed | 3.48e-04 | 10 | 98 | 2 | 18434328 | ||
| Pubmed | 4.25e-04 | 222 | 98 | 5 | 37071664 | ||
| Pubmed | Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. | 4.25e-04 | 11 | 98 | 2 | 15949438 | |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 4.34e-04 | 52 | 98 | 3 | 30655611 | |
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 19095005 | ||
| Pubmed | Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression. | 5.09e-04 | 12 | 98 | 2 | 15716349 | |
| Pubmed | 5.13e-04 | 130 | 98 | 4 | 12421765 | ||
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 5.68e-04 | 57 | 98 | 3 | 23788249 | |
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 17670746 | ||
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 6.61e-04 | 60 | 98 | 3 | 29055695 | |
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 7.00e-04 | 14 | 98 | 2 | 28724790 | |
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 21795692 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 7.40e-04 | 861 | 98 | 9 | 36931259 | |
| Pubmed | 8.06e-04 | 15 | 98 | 2 | 12056414 | ||
| Pubmed | Germline genomic variants associated with childhood acute lymphoblastic leukemia. | 8.06e-04 | 15 | 98 | 2 | 19684603 | |
| Pubmed | 8.06e-04 | 15 | 98 | 2 | 18854777 | ||
| Pubmed | 9.12e-04 | 263 | 98 | 5 | 34702444 | ||
| Pubmed | 9.19e-04 | 16 | 98 | 2 | 10932191 | ||
| Pubmed | 9.52e-04 | 68 | 98 | 3 | 20496165 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 9.62e-04 | 1082 | 98 | 10 | 38697112 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF134 ZNF274 ZNF175 ZNF571 ZNF230 RYR1 ZNF419 ZNF776 ZNF526 ZNF382 STRN4 ZNF542P ZNF614 ZNF345 | 2.52e-07 | 1192 | 98 | 14 | chr19q13 |
| Cytoband | Xq13 | 3.46e-04 | 13 | 98 | 2 | Xq13 | |
| Cytoband | 19q13.12 | 5.06e-04 | 72 | 98 | 3 | 19q13.12 | |
| Cytoband | 19q13.43 | 8.78e-04 | 87 | 98 | 3 | 19q13.43 | |
| Cytoband | 11p15.3 | 9.22e-04 | 21 | 98 | 2 | 11p15.3 | |
| Cytoband | 19p12 | 9.69e-04 | 90 | 98 | 3 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 2.32e-03 | 122 | 98 | 3 | chr19p12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 ZNF134 SP3 ZFAT ZNF562 ZNF274 ZNF157 ZNF175 ZNF521 ZNF407 ZNF571 ZNF397 ZNF230 ZNF251 OVOL2 ZNF419 ZNF776 ZNF526 OVOL1 ZNF100 FEZF1 ZNF382 ZNF728 ZNF253 ZNF506 ZNF542P PRDM15 ZNF614 ZNF653 GLIS1 ZNF345 | 5.53e-25 | 718 | 71 | 31 | 28 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.55e-05 | 3 | 71 | 2 | 287 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 8.41e-07 | 199 | 98 | 8 | M3417 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN | 9.15e-06 | 196 | 98 | 7 | M6073 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 1.04e-05 | 200 | 98 | 7 | M6447 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-06 | 179 | 97 | 6 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-06 | 198 | 97 | 6 | d021d0edb6aba2f15c51a3ec4e08c7233d0c1962 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.91e-06 | 199 | 97 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| Disease | aortic valve stenosis (is_marker_for) | 4.91e-06 | 11 | 93 | 3 | DOID:1712 (is_marker_for) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.94e-05 | 3 | 93 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.94e-05 | 3 | 93 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | clonorchiasis (is_marker_for) | 2.94e-05 | 3 | 93 | 2 | DOID:13767 (is_marker_for) | |
| Disease | Pilomatrixoma | 5.87e-05 | 4 | 93 | 2 | C0206711 | |
| Disease | Autism Spectrum Disorders | 1.54e-04 | 85 | 93 | 4 | C1510586 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.75e-04 | 40 | 93 | 3 | EFO_0004746 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 4.35e-04 | 10 | 93 | 2 | OBA_2045132 | |
| Disease | phospholipids in very small VLDL measurement | 5.66e-04 | 51 | 93 | 3 | EFO_0022300 | |
| Disease | total lipids in medium LDL | 5.99e-04 | 52 | 93 | 3 | EFO_0022180 | |
| Disease | integral membrane protein 2B measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0802634 | |
| Disease | wet macular degeneration | 8.72e-04 | 14 | 93 | 2 | EFO_0004683 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 9.56e-04 | 61 | 93 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 1.00e-03 | 15 | 93 | 2 | EFO_0022328 | |
| Disease | level of Sterol ester (27:1/18:0) in blood serum | 1.15e-03 | 16 | 93 | 2 | OBA_2045196 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.30e-03 | 17 | 93 | 2 | EFO_0022232 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.62e-03 | 19 | 93 | 2 | EFO_0802076 | |
| Disease | serum alanine aminotransferase measurement | 1.69e-03 | 869 | 93 | 9 | EFO_0004735 | |
| Disease | mucocutaneous lymph node syndrome | 1.80e-03 | 76 | 93 | 3 | EFO_0004246 | |
| Disease | sphingomyelin measurement | 1.89e-03 | 278 | 93 | 5 | EFO_0010118 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 1.98e-03 | 21 | 93 | 2 | EFO_0022246 | |
| Disease | Hodgkins lymphoma | 2.24e-03 | 82 | 93 | 3 | EFO_0000183 | |
| Disease | sphingomyelin 24:1 measurement | 2.38e-03 | 23 | 93 | 2 | EFO_0010398 | |
| Disease | eosinophil percentage of leukocytes | 2.48e-03 | 746 | 93 | 8 | EFO_0007991 | |
| Disease | sexual dimorphism measurement | ZFAT APOB GRM4 FARP2 SPTBN5 OVOL1 ANKRD11 SNRPC HERPUD1 AP3D1 | 2.55e-03 | 1106 | 93 | 10 | EFO_0021796 |
| Disease | asthma | 2.58e-03 | 751 | 93 | 8 | MONDO_0004979 | |
| Disease | Behcet Syndrome | 2.59e-03 | 24 | 93 | 2 | C0004943 | |
| Disease | Eczema | 3.03e-03 | 310 | 93 | 5 | HP_0000964 | |
| Disease | macular degeneration (is_marker_for) | 3.04e-03 | 26 | 93 | 2 | DOID:4448 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QARKLEHVIKVAHAC | 96 | O60583 | |
| KGKLEKCCRHLQHLE | 1186 | O94986 | |
| IRKCFGIQQHHKITK | 266 | Q96DX5 | |
| HGHLEAVKVLLKRCQ | 181 | Q6P6B7 | |
| HKHKNKEKGQCSISQ | 636 | Q6UB99 | |
| DETLGHSKHCRNKQK | 401 | Q96NH3 | |
| NAVHLKIKHRCTIEG | 461 | Q6ZN30 | |
| RHALKKGSHVKKCTN | 376 | Q14833 | |
| THLEHQQRIESKVCK | 261 | Q71F23 | |
| HCVLNQEVRKHLKGV | 2701 | Q9NYQ6 | |
| KKEKLIRDVAHCHGI | 606 | Q03468 | |
| KGACVERHNLNKHRV | 501 | Q8TE58 | |
| IQGHHVCLLVKKGEN | 1111 | O14617 | |
| LKHQHRCVAIFKDKQ | 211 | P78406 | |
| CIQHLQLIAEKHKGE | 176 | O43502 | |
| QEKRHVLHLVCNVKS | 76 | Q15011 | |
| LIKNGSKKVIQHCRE | 81 | Q8IYW4 | |
| KCKRLEQELHHVKEQ | 276 | Q8TD10 | |
| IAGFIIKHICQKHLQ | 4576 | Q5CZC0 | |
| NAVKVRHILCEKHGK | 36 | Q9Y237 | |
| LKVAKKVAHLAGCNH | 261 | Q5XG92 | |
| RGKGKIRHHISCIEK | 971 | Q8NEV8 | |
| QRCSLESHLKKIHGV | 186 | Q9BRP0 | |
| RCSLESHLKKIHGVQ | 186 | O14753 | |
| KDHLGHINECLKVLQ | 326 | Q96LP2 | |
| NLRKNKAGVVIHCNH | 226 | Q9H8P0 | |
| AKRKHVAEAICKEQH | 251 | P04114 | |
| VKVTKQHNDECKHLL | 131 | P39748 | |
| KTGRKHKRHLVLAAC | 71 | O95760 | |
| HHSKKGQVAKLDLEC | 201 | Q13145 | |
| ICHLQGDHSVLQKKL | 736 | Q4L180 | |
| ILHQLKRCQNHNKTK | 221 | P51685 | |
| HNIAKQLCLHVSKGA | 546 | Q8NCL4 | |
| GKLQECKQTLLKARH | 731 | Q6PD62 | |
| HQLKRCKIAGVNIKT | 326 | Q9BXR6 | |
| IKGHGHKRIVVLKND | 1546 | Q9Y4F3 | |
| HSAKEQQVRKKLHAG | 346 | Q8NBF1 | |
| CLEKILEFHQKHVGQ | 196 | O94887 | |
| KHGRNHKVLDVLCSL | 591 | P21817 | |
| LDKHGRNHKVLDVLC | 601 | Q92736 | |
| RHGNLCLDKINVLHK | 526 | O15294 | |
| QRLACIKKHLKSQGI | 626 | Q92833 | |
| GDINKLKIEHTCRLH | 146 | Q96KS9 | |
| CVDRLGLKEHVKSHK | 136 | Q9NQ35 | |
| IKHQHREQGSIKCKL | 591 | Q8TBY8 | |
| KKQESNHLQIHLCRK | 151 | Q9NZ71 | |
| VAKKAIRKLKQGHCT | 236 | Q5HYW3 | |
| VISLDHKNKKHIRGC | 71 | Q9BQF6 | |
| RKTHCSGRKHKENVK | 21 | P09234 | |
| KNRKKCVNVTTKGLH | 601 | Q9H3W5 | |
| QKVNMLKHCKRHTGI | 1151 | P57071 | |
| HKIIHTQEKPHKCNQ | 306 | A0PJY2 | |
| NLDGKLHQHVVKCTV | 66 | Q8N4L2 | |
| EICAKLSHVIKKQHR | 786 | Q7Z333 | |
| GRKRHCKTKHLEQNG | 621 | Q8NCN4 | |
| HKHPNNLKVACEKTV | 246 | O00764 | |
| CLNGAQSLHRKHKEL | 1551 | Q9NRC6 | |
| KTNLKKCMDHIQHRL | 161 | Q9UPX8 | |
| KHCNGILKELLSKKH | 351 | P25440 | |
| DGKDKTGVHRKQCHL | 401 | Q7Z7G1 | |
| IHVLKALNRCQLKHT | 5061 | Q63HN8 | |
| NVIHQKGCFHKLLKI | 196 | Q9UKR8 | |
| KVHKEHDNKLNQCLI | 156 | Q8IYN0 | |
| HLKQCVAVHTGKKSE | 246 | Q6V9R5 | |
| NHVNLVHRKGKTKVC | 486 | Q96CK0 | |
| MQLTLHKRNHTQKKC | 111 | Q5EBM4 | |
| KRHVIQKHSNILLKC | 786 | Q9P243 | |
| KKSLCQHRRTHTGEK | 426 | P51786 | |
| QGLLKVLHKQCHHKR | 76 | Q96C74 | |
| QKTCRKHRKENQGSH | 196 | P25445 | |
| RGTNLGKKKQHICHI | 611 | Q02447 | |
| VKHNHLENQGKVHKC | 771 | Q96K83 | |
| KHNSRVKIHQKSCER | 461 | Q96GC6 | |
| CIHKLGHRENLCVKQ | 116 | Q6ZV73 | |
| KCSNSKRHKIRHTGK | 156 | P0DKX0 | |
| CNHSLKKEERKRNQH | 581 | Q8IZH2 | |
| HGGCNKVLRELVKHK | 46 | Q9BVS4 | |
| LHLRQLCEAKQKTHV | 516 | O60343 | |
| QLKKGCKSVGEHKVH | 111 | O75346 | |
| CHEQHLKIAKDLGNK | 376 | Q96AY4 | |
| QHQKVHSGETRKCRK | 506 | Q9BRH9 | |
| LIRHRKIHTGEKACK | 356 | Q8NF99 | |
| RAILQVHCKLHTGEK | 236 | Q9UIE0 | |
| QKLILRRHKKCGHDN | 96 | Q6ZN08 | |
| RRHKKCGHDNLQLKK | 101 | Q6ZN08 | |
| VCGKGFKKLIHVRNH | 476 | Q8TF50 | |
| KTCVQEITAHRKKHE | 711 | Q9NRL3 | |
| QHKKSHNGKKLCELE | 471 | Q14585 | |
| RHCATKKHKGRVEIE | 896 | Q9C0G0 | |
| KELCLNHKRAEIQGK | 81 | Q1A5X7 | |
| QKICLIQHERCHTGK | 466 | Q8N883 | |
| CKSNLIVHQKTHKVE | 531 | Q96SR6 | |
| QHQKQHCGEKPLKRQ | 126 | Q96HQ0 | |
| GQKRDVCEHHGKKLQ | 91 | Q8IYM9 | |
| HNIEKCSEVKKHRNT | 161 | Q7Z3V5 | |
| GGCQQKAIHSKRKTH | 146 | P52741 | |
| ALNKHKKIHIRQKPC | 411 | Q5JVG8 | |
| QCRKVCGHKQSLKQH | 256 | Q9Y473 | |
| CFRQKGNLIKHQRVH | 496 | Q68DI1 |